Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study-Reference-Cited by-同舟云学术

Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study

Published:2016-07-01 Issue:7 Volume:39 Page:1379-1387
ISSN:1550-9109
Container-title:Sleep
language:en
Short-container-title:

Author:

Ruoff Chad¹,Swick Todd J.²,Doekel Robert³,Emsellem Helene A.⁴,Feldman Neil T.⁵,Rosenberg Russell⁶,Bream Gary⁷,Khayrallah Moise A.⁷,Lu Yuan⁸,Black Jed¹⁸

Affiliation:

1. Stanford University Sleep Medicine Center, Redwood City, CA

2. Neurology and Sleep Medicine Consultants of Houston, University of Texas-Houston School of Medicine, Houston, TX

3. Sleep Disorders Center of Alabama, Birmingham, AL

4. The Center for Sleep & Wake Disorders, Chevy Chase, MD

5. St Petersburg Sleep Disorders Center at Palms of Pasadena Hospital, St Petersburg, FL

6. NeuroTrials Research, Atlanta, GA

7. Aerial BioPharma, Morrisville, NC

8. Jazz Pharmaceuticals, Inc., Palo Alto, CA

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Clinical Neurology

Link

http://academic.oup.com/sleep/article-pdf/39/7/1379/26674021/sleep-39-7-1379.pdf

Reference33 articles.

1. The International Classification of Sleep Disorders;American Academy of Sleep Medicine,2014

2. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association,2013

4. Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners;Jennum;Sleep Med,2012

5. The Burden of Narcolepsy Disease (BOND) Study: Healthcare Utilization and Cost Findings;Black;Sleep Med,2014

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hits and misses with animal models of narcolepsy and the implications for drug discovery;Expert Opinion on Drug Discovery;2024-05-15

2. Trends and Variation in Issuance of High-Cost Narcolepsy Drugs by NHS England Organisations and Regions from 2019-2022;2024

3. Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea;CNS Drugs;2023-10-17

4. Pharmacological options for narcolepsy: are they the way forward?;Expert Review of Neurotherapeutics;2023-08-29

5. Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis;Nature and Science of Sleep;2023-04